abstract |
the invention relates to methods for treating hip associated vasculitis in a human in need thereof, the method comprising administering to the human a therapeutically effective amount of avacopan, or a pharmaceutically acceptable salt thereof, so that the level of factor of complement in plasma bb, c3a or c5a does not change significantly in humans during treatment. |